FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $847,730 | +408.1% | 256,888 | +338.8% | 0.03% | +450.0% |
| Q1 2023 | $166,830 | -60.9% | 58,537 | 0.0% | 0.01% | -62.5% |
| Q4 2022 | $426,149 | +48.5% | 58,537 | 0.0% | 0.02% | +45.5% |
| Q2 2022 | $287,000 | -84.3% | 58,537 | -24.3% | 0.01% | -82.8% |
| Q1 2022 | $1,828,000 | +33.7% | 77,293 | 0.0% | 0.06% | +45.5% |
| Q4 2021 | $1,367,000 | +10.4% | 77,293 | +76.1% | 0.04% | +10.0% |
| Q3 2021 | $1,238,000 | – | 43,898 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |